Andrew Feinberg is the founder of BostonGene. BostonGene has raised $200M in total funding. Latest round: Series B. Based in Waltham, United States.
Andrew Feinberg is the President and CEO of BostonGene, a company that develops an AI foundation model for tumor and immune biology. BostonGene's AI platform integrates multimodal biological data to transform pharmaceutical research, optimize clinical trial design, and advance precision oncology. He also serves as the Chairman and CEO of Netcracker Technology. Feinberg is delivering a keynote at Mobile World Congress Barcelona 2026 on the topic of AI governance and its impact on industries like precision oncology and drug development, as well as global telecommunications infrastructure.
Full founder directory · Investor directory · Company funding database · Fundraising library